Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.

by Jason M D'Antonio, Donald J Vander Griend, Lizamma Antony, George Ndikuyeze, Susan L Dalrymple, Shahriar Koochekpour, John T Isaacs
Published 2010-07-01

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer

by W. Nathaniel Brennen, Yezi Zhu, Ilsa M. Coleman, Susan L. Dalrymple, Lizamma Antony, Radhika A. Patel, Brian Hanratty, Roshan Chikarmane, Alan K. Meeker, S. Lilly Zheng, Jody E. Hooper, Jun Luo, Angelo M. De Marzo, Eva Corey, Jianfeng Xu, Srinivasan Yegnasubramanian, Michael C. Haffner, Peter S. Nelson, William G. Nelson, William B. Isaacs, John T. Isaacs
Published 2021-04-01